cAmbly: A non-toxic cell-penetrating peptide derived from Amblyomin-X with targeted delivery to mitochondrial and cytoplasmic proteins

• Marcus Vinicius Buri ,

  Contributed equally to this work with: Marcus Vinicius Buri, Graciana Yokota Garavelli

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  ⨯
• Graciana Yokota Garavelli ,

  Contributed equally to this work with: Marcus Vinicius Buri, Graciana Yokota Garavelli

  Roles Formal analysis, Investigation

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  ⨯
• Hugo Vigerelli,

  Roles Data curation, Formal analysis, Investigation, Methodology

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  ⨯
• Marcelo Medina de Souza,

  Roles Data curation, Formal analysis, Methodology

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  https://orcid.org/0000-0003-1706-9285

  ⨯
• Aline Ramos Maia Lobba,

  Roles Conceptualization

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  https://orcid.org/0000-0003-1827-3528

  ⨯
• Sonja Ghidelli-Disse,

  Roles Methodology

  Affiliation Cellzome GmbH, a GSK Company, Heidelberg, Germany

  ⨯
• Ana Marisa Chudzinski-Tavassi

  Roles Conceptualization, Supervision

  * E-mail: ana.chudzinski@butantan.gov.br

  Affiliation CENTD, Centre of Excellence in New Target Discovery, Instituto Butantan, São Paulo, Brazil

  https://orcid.org/0000-0001-7717-7013

  ⨯